Relationship between pre-pregnancy body-mass-index and gestational age-specific risk of stillbirth and perinatal death in women with chronic hypertension.

Am J Obstet Gynecol

Department of Obstetrics and Gynaecology, University of British Columbia and the Children's and Women's Hospital and Health Centre of British Columbia, Vancouver, BC, Canada; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.

Published: December 2024

Background: Obesity is a risk factor for stillbirth and perinatal death and is often accompanied by chronic hypertension; however, there are few studies on the relationship between pre-pregnancy BMI and gestational age (GA)-specific rates of stillbirth and perinatal death in women with chronic hypertension.

Objective: The objective of this study was to examine the relationship between pre-pregnancy BMI and GA-specific risk of stillbirth and perinatal death in the presence/absence of chronic hypertension.

Methods: This was a retrospective cohort study of all singleton births in the United States in 2016-17. Data were obtained from the live birth and fetal death certificates available from the National Center for Health Statistics. We used Piecewise Additive Mixed Models to assess the GA-specific relationship between pre-pregnancy BMI and stillbirth and perinatal death in women with and without chronic hypertension, adjusted for potential confounders. Results were expressed as GA-specific adjusted hazard ratios (aHR) and 95% confidence intervals (CI).

Results: A total of 7,365,797 women were included among whom 255,464 (3.5%) were underweight, 3,233,710 (43.9%) had normal BMI, 1,925,510 (26.1%) were overweight, and 1,065,958 (14.5%), 518,543 (7.0%), and 366,612 (5.0%) had obesity class I, II and III, respectively. Overall, stillbirth rates increased with increasing BMI and were higher in women with chronic hypertension (14.2 per 1000 total births) than among those without (4.7 per 1000 total births). The cumulative incidence of stillbirth increased at each gestational week, with the gradient increasing by BMI category in women without chronic hypertension. However, this relationship was modified in women with chronic hypertension, for whom the increased risk of stillbirth by higher BMI was reversed at 26-35 weeks' gestation. For example, at 31 weeks' gestation, the aHR for women with a BMI of 40 kg/m vs 20 kg/m and chronic hypertension was 0.78 (95% CI = 0.65, 0.93), while aHR for similar women without chronic hypertension was 1.39 (95% CI = 1.30, 1.48). Results were similar for perinatal death.

Conclusion: The relationship between pre-pregnancy BMI and stillbirth is modified in the presence of chronic hypertension at 26-35 weeks' gestation, when elevated BMI is associated with a lower or similar relative risk of stillbirth and perinatal death. Nevertheless, women with chronic hypertension and elevated BMI have higher absolute risks of stillbirth and perinatal death at all gestations. Our results suggest that in obese women, optimal timing of delivery may differ depending on the presence or absence of chronic hypertension.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2024.12.007DOI Listing

Publication Analysis

Top Keywords

chronic hypertension
44
women chronic
32
stillbirth perinatal
28
perinatal death
28
relationship pre-pregnancy
20
risk stillbirth
16
death women
16
pre-pregnancy bmi
16
chronic
13
weeks' gestation
12

Similar Publications

The serum uric acid-to-creatinine ratio (UCR) may be a simple method for assessing xanthine oxidase overactivation, which may contribute to an increase in serum uric acid production and oxidative stress. In this study, we investigated the nonlinear association between the UCR and long-term mortality in patients with hypertension. Data were acquired from the National Health and Nutrition Examination Survey database, and a total of 11,346 patients with hypertension were included.

View Article and Find Full Text PDF

HIF-1α mediates hypertension and vascular remodeling in sleep apnea via hippo-YAP pathway activation.

Mol Med

December 2024

Department of Otorhinolaryngology/Head and Neck, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, No.3 East Qingchun Road, Hangzhou, 310020, Zhejiang, China.

Background: Sleep apnea syndrome (SAS) is associated with hypertension and vascular remodeling. Hypoxia-inducible factor-1α (HIF-1α) and the Hippo-YAP pathway are implicated in these processes, but their specific roles remain unclear. This study investigated the HIF-1α/Hippo-YAP pathway in SAS-related hypertension.

View Article and Find Full Text PDF

Background: Reducing inequities in hypertension control among those affected in low- and middle-income countries requires person-centred health system responses based on a contextualised understanding of the choices and care pathways taken by those who rely on the services provided, particularly those from poor and marginalised communities. We examine patterns of care seeking and pathways followed by individuals with hypertension from low-income households in the Philippines and Malaysia. This study aims to fill a significant gap in the literature by analysing the stages at which individuals make decisions that may affect the successful control of their blood pressure.

View Article and Find Full Text PDF

Background: Self-reported mental stress is not consistently recognized as a risk factor for stroke. This prompted development of a novel algorithm for stress-phenotype indices to quantify chronic stress prevalence in relation to a modified stroke risk score in a South African cohort. The algorithm is based on biomarkers adrenocorticotrophic hormone, high-density lipoprotein cholesterol, high-sensitive cardiac-troponin-T, and diastolic blood pressure which exemplifies the stress-ischemic-phenotype index.

View Article and Find Full Text PDF

Chronic cerebral ischemia (CCI) is one of the most common forms of cerebrovascular disease, which affects a significant number of patients, often leading to disability, cognitive impairment and dementia. The analysis of modern data on the pathogenesis and risk factors for the development of CCI, as well as on the mechanisms of action of Mexidol on various links in the pathogenesis of CCI. A systematic search was conducted in the PubMed, MEDLINE and Google Scholar databases, on Russian and English-language sites with open access publications on the problem of CCI and on the drug Mexidol in the period from 2014 to 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!